Deepak shares a clear point of view on why data ecosystems, not isolated enterprise AI strategies, will shape the future of biopharma, and how organizations can unlock value even with fragmented, limited, or non-traditional datasets. He also highlighted why AI governance must start with business strategy, enabling not just control and compliance, but measurable ROI and value-based pricing models.
No blogs found.
Get Latest updates and industry insights every month.